⌘K

Login Start Free

Home/Filings/4/0001856094-25-000006

4//SEC Filing

Borgeson Blake 4

Accession 0001856094-25-000006

CIK 0001601830other

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:51 PM ET

Size

4.8 KB

Accession

0001856094-25-000006

Insider Transaction Report

Form 4

Period: 2025-12-02

RECURSION PHARMACEUTICALS, INC.RXRX

Director

Transactions

Sale
Class A Common Stock
2025-12-02$4.37/sh−220,000$961,400→ 6,869,863 total

Footnotes (1)

[F1]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.

Documents

1 file

4
wk-form4_1764885089.xmlPrimary
FORM 4

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1

filerCIK 0001856094

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 4:51 PM ET
Size: 4.8 KB

View on SEC.gov